Brief: Genmab Outlook FY Revenue USD 4,065-4,395 Million
Feb 17 (Reuters) - Genmab outlook FY operating expenses USD -2,910 to -2,710 million. outlook FY operating profit USD 900-1,400 million
Recent news on Genmab A/S
See all newsBrief: Genmab Q3 Net Sales Of Darzalex At $4.24 Bln
European shares rise as retreating bond yields and oil prices boost risk appetite
Live Markets: Oil prices can rise even with a new MoU
Live Markets: What the AI capex cycle might mean for European growth
Live Markets: Ignore politics and buy the dip in Spain's Bonos